Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

PURPOSE: Although inhibitors of vascular endothelial growth factor and inhibitors of epidermal growth factor receptor (EGFRi) are commonly used for the treatment of metastatic colorectal cancer (mCRC), the optimal sequencing of these agents is currently unclear. METHODS: A national registry of targe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Manag Res
Asıl Yazarlar: Buchler, Tomas, Chloupkova, Renata, Poprach, Alexandr, Fiala, Ondrej, Kiss, Igor, Kopeckova, Katerina, Dusek, Ladislav, Veskrnova, Veronika, Slavicek, Lubomir, Kohoutek, Milan, Finek, Jindrich, Svoboda, Marek, Petruzelka, Lubos, Melichar, Bohuslav
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314050/
https://ncbi.nlm.nih.gov/pubmed/30643461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183093
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller